Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
Syc-Mazurek SB, Zhao-Fleming H, Guo Y, Tisavipat N, Chen JJ, Zekeridou A, Kournoutas I, Orme JJ, Block MS, Lucchinetti CF, Mustafa R, Flanagan EP. Syc-Mazurek SB, et al. Among authors: block ms. Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200249. doi: 10.1212/NXI.0000000000200249. Epub 2024 May 2. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38696737 Free PMC article.
Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy.
Saliba AN, Xie Z, Higgins AS, Andrade-Gonzalez XA, Fuentes-Bayne HE, Hampel PJ, Kankeu Fonkoua LA, Childs DS, Rakshit S, Bezerra ED, Kommalapati A, Lou Y, Rivera CE, Price KA, Chintakuntlawar A, Yan Y, Schwecke AJ, Block MS, Thanarajasingam U, Thanarajasingam G, Wolanskyj-Spinner AP, Marshall AL, Kottschade LA, Go RS, Al-Kali A. Saliba AN, et al. Among authors: block ms. Am J Hematol. 2021 Oct 1;96(10):E362-E367. doi: 10.1002/ajh.26273. Epub 2021 Jul 2. Am J Hematol. 2021. PMID: 34137072 Free article. No abstract available.
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing.
Barman H, Venkateswaran S, Santo AD, Yoo U, Silvert E, Rao K, Raghunathan B, Kottschade LA, Block MS, Chandler GS, Zalis J, Wagner TE, Mohindra R. Barman H, et al. Among authors: block ms. JCO Clin Cancer Inform. 2024 Apr;8:e2300151. doi: 10.1200/CCI.23.00151. JCO Clin Cancer Inform. 2024. PMID: 38687915 Free PMC article.
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study.
Holmberg CJ, Ny L, Hieken TJ, Block MS, Carr MJ, Sondak VK, Örtenwall C, Katsarelias D, Dimitriou F, Menzies AM, Saw RP, Rogiers A, Straker RJ 3rd, Karakousis G, Applewaite R, Pallan L, Han D, Vetto JT, Gyorki DE, Tie EN, Vitale MG, Ascierto PA, Dummer R, Cohen J, Hui JY, Schachter J, Asher N, Helgadottir H, Chai H, Kroon H, Coventry B, Rothermel LD, Sun J, Carlino MS, Duncan Z, Broman K, Weber J, Lee AY, Berman RS, Teras J, Ollila DW, Long GV, Zager JS, van Akkooi A, Olofsson Bagge R. Holmberg CJ, et al. Among authors: block ms. Eur J Cancer. 2022 Jul;169:210-222. doi: 10.1016/j.ejca.2022.03.041. Epub 2022 May 26. Eur J Cancer. 2022. PMID: 35644725 Free article.
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations.
DeLeon TT, Almquist DR, Kipp BR, Langlais BT, Mangold A, Winters JL, Kosiorek HE, Joseph RW, Dronca RS, Block MS, McWilliams RR, Kottschade LA, Rumilla KM, Voss JS, Seetharam M, Sekulic A, Markovic SN, Bryce AH. DeLeon TT, et al. Among authors: block ms. PLoS One. 2020 Mar 20;15(3):e0230306. doi: 10.1371/journal.pone.0230306. eCollection 2020. PLoS One. 2020. PMID: 32196516 Free PMC article.
Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift.
Hieken TJ, Kreidieh F, Aedo-Lopez V, Block MS, McArthur GA, Amaria RN. Hieken TJ, et al. Among authors: block ms. Am Soc Clin Oncol Educ Book. 2023 Jan;43:e390614. doi: 10.1200/EDBK_390614. Am Soc Clin Oncol Educ Book. 2023. PMID: 37116111 Free article.
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
Sener U, Webb M, Breen WG, Neth BJ, Laack NN, Routman D, Brown PD, Mahajan A, Frechette K, Dudek AZ, Markovic SN, Block MS, McWilliams RR, Dimou A, Kottschade LA, Montane HN, Kizilbash SH, Campian JL. Sener U, et al. Among authors: block ms. J Immunother Precis Oncol. 2024 Feb 5;7(1):1-6. doi: 10.36401/JIPO-23-20. eCollection 2024 Feb. J Immunother Precis Oncol. 2024. PMID: 38327758 Free PMC article.
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade.
Luo Y, Shreeder B, Jenkins JW, Shi H, Lamichhane P, Zhou K, Bahr DA, Kurian S, Jones KA, Daum JI, Dutta N, Necela BM, Cannon MJ, Block MS, Knutson KL. Luo Y, et al. Among authors: block ms. J Immunother Cancer. 2023 Nov;11(11):e007661. doi: 10.1136/jitc-2023-007661. J Immunother Cancer. 2023. PMID: 37918918 Free PMC article.
249 results